{"id":"W206963652","doi":"10.1021/ja4049493","title":"H<sub>4</sub>octapa-Trastuzumab: Versatile Acyclic Chelate System for <sup>111</sup>In and <sup>177</sup>Lu Imaging and Therapy","year":2013,"lang":"en","type":"article","venue":"Journal of the American Chemical Society","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; TRIUMF","funders":"National Cancer Institute","keywords":"Trastuzumab; Chemistry; Biodistribution; DOTA; Chelation; In vivo; Conjugate; Radioimmunotherapy; Radiochemistry; Cancer; Antibody; In vitro; Monoclonal antibody; Biochemistry; Breast cancer; Internal medicine; Medicine; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001234811,0.000363456,0.0001907237,0.0001425685,0.0001007302,0.0002146207,0.0003363071,0.0002441697,0.0009694785],"category_scores_gemma":[0.0001116978,0.0001323398,0.0001105381,0.0001246275,0.0001539997,0.000170469,0.0002769376,0.0002928062,0.0005094747],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003492238,"about_ca_system_score_gemma":0.0002012949,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000529825,"about_ca_topic_score_gemma":0.0006464592,"domain_scores_codex":[0.9999194,0.00001438576,0.000005033309,0.00002010455,0.00001868416,0.00002233212],"domain_scores_gemma":[0.9999413,0.000006578667,0.00001801289,0.000005018819,0.00001064216,0.00001847287],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00009244035,0.00001361884,0.00008885875,0.00005699752,0.0000047202,0.00005668739,0.00001681721,0.0001557142,0.9959714,0.0002439929,0.00009334572,0.003205401],"study_design_scores_gemma":[0.00001388291,0.0002103422,0.0004388714,0.000003910765,0.0000135393,0.0002080928,0.000008429074,0.0006105082,0.9910539,0.00003917296,0.007391321,0.00000789296],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.957242,0.003453109,0.03154638,0.0002224904,0.00006351987,0.0002081777,0.0005527475,0.0005106704,0.006200824],"genre_scores_gemma":[0.9757783,0.00143178,0.01645863,0.0001438675,0.00002596853,0.0001441511,0.0006495371,0.00006612414,0.005301759],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0009694785,"threshold_uncertainty_score":0.003243208,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01192009649366285,"score_gpt":0.2724000379543057,"score_spread":0.2604799414606429,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}